Literature DB >> 26641861

LL-37 Triggers Formation of Streptococcus pyogenes Extracellular Vesicle-Like Structures with Immune Stimulatory Properties.

Julia Uhlmann1, Manfred Rohde, Nikolai Siemens, Bernd Kreikemeyer, Peter Bergman, Linda Johansson, Anna Norrby-Teglund.   

Abstract

Reports have shown that the antimicrobial peptide LL-37 is abundantly expressed but has limited bactericidal effect in Streptococcus pyogenes infections. At sub-inhibitory concentrations, LL-37 has been reported to alter virulence gene expression. Here, we explored the interaction of S. pyogenes strains with LL-37, focusing on bacterial growth, cell surface alterations and pro-inflammatory responses. Bioscreen turbidity measurements of strain 5448 cultured in the presence or absence of LL-37 confirmed the poor antimicrobial effect, and revealed a significant increase in turbidity of bacterial cultures exposed to sub-inhibitory concentrations of LL-37. However, this was not linked to increased bacterial counts. Electron microscopy of LL-37-exposed bacteria revealed the presence of vesicle-like structures on the bacterial surface. The vesicles stained positive for LL-37 and were released from the bacterial surface. Concentrated supernatants enriched in these structures had a broader protein content, including several virulence factors, compared to supernatants from untreated bacteria. The supernatants from LL-37-exposed bacteria were pro-inflammatory and elicited resistin and myeloperoxidase release from neutrophils. This is the first report on S. pyogenes extracellular vesicle-like structures formed at the bacterial surface in response to LL-37. The associated increased pro-inflammatory activity further implicates LL-37 as a potential factor involved in S. pyogenes pathogenesis.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26641861      PMCID: PMC6738779          DOI: 10.1159/000441896

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  40 in total

1.  A microdomain for protein secretion in Gram-positive bacteria.

Authors:  Jason Rosch; Michael Caparon
Journal:  Science       Date:  2004-06-04       Impact factor: 47.728

2.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus.

Authors:  R A Dorschner; V K Pestonjamasp; S Tamakuwala; T Ohtake; J Rudisill; V Nizet; B Agerberth; G H Gudmundsson; R L Gallo
Journal:  J Invest Dermatol       Date:  2001-07       Impact factor: 8.551

3.  Release of Shiga toxin by membrane vesicles in Shigella dysenteriae serotype 1 strains and in vitro effects of antimicrobials on toxin production and release.

Authors:  Shanta Dutta; Ken-ichiro Iida; Akemi Takade; Yuko Meno; Gopinath Balakrish Nair; Shin-ichi Yoshida
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

4.  Innate antimicrobial peptide protects the skin from invasive bacterial infection.

Authors:  V Nizet; T Ohtake; X Lauth; J Trowbridge; J Rudisill; R A Dorschner; V Pestonjamasp; J Piraino; K Huttner; R L Gallo
Journal:  Nature       Date:  2001-11-22       Impact factor: 49.962

5.  SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides.

Authors:  Inga-Maria Frick; Per Akesson; Magnus Rasmussen; Artur Schmidtchen; Lars Björck
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

6.  The M protein is dispensable for maturation of streptococcal cysteine protease SpeB.

Authors:  Björn Zimmerlein; Hae-Sun Park; Shaoying Li; Andreas Podbielski; P Patrick Cleary
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases.

Authors:  S Chatellier; N Ihendyane; R G Kansal; F Khambaty; H Basma; A Norrby-Teglund; D E Low; A McGeer; M Kotb
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37.

Authors:  Patrik Nyberg; Magnus Rasmussen; Lars Björck
Journal:  J Biol Chem       Date:  2004-11-01       Impact factor: 5.157

9.  Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37.

Authors:  Artur Schmidtchen; Inga-Maria Frick; Emma Andersson; Hans Tapper; Lars Björck
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

10.  Subcellular sites for bacterial protein export.

Authors:  Nathalie Campo; Harold Tjalsma; Girbe Buist; Dariusz Stepniak; Michel Meijer; Marten Veenhuis; Martin Westermann; Jörg P Müller; Sierd Bron; Jan Kok; Oscar P Kuipers; Jan D H Jongbloed
Journal:  Mol Microbiol       Date:  2004-09       Impact factor: 3.501

View more
  15 in total

Review 1.  Variation, Indispensability, and Masking in the M protein.

Authors:  Partho Ghosh
Journal:  Trends Microbiol       Date:  2017-08-31       Impact factor: 17.079

2.  Prothrombotic and Proinflammatory Activities of the β-Hemolytic Group B Streptococcal Pigment.

Authors:  Nikolai Siemens; Sonja Oehmcke-Hecht; Jörn Hoßmann; Sebastian B Skorka; Roel H T Nijhuis; Corinne Ruppen; Steinar Skrede; Manfred Rohde; Daniel Schultz; Michael Lalk; Andreas Itzek; Dietmar H Pieper; Christiaan J van den Bout; Eric C J Claas; Ed J Kuijper; Robert Mauritz; Parham Sendi; Herman F Wunderink; Anna Norrby-Teglund
Journal:  J Innate Immun       Date:  2019-11-19       Impact factor: 7.349

3.  A Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A Streptococcus.

Authors:  Ulrike Resch; James Anthony Tsatsaronis; Anaïs Le Rhun; Gerald Stübiger; Manfred Rohde; Sergo Kasvandik; Susanne Holzmeister; Philip Tinnefeld; Sun Nyunt Wai; Emmanuelle Charpentier
Journal:  MBio       Date:  2016-11-01       Impact factor: 7.867

4.  Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids.

Authors:  Elizabeth V K Ledger; Vera Pader; Andrew M Edwards
Journal:  Microbiology (Reading)       Date:  2017-09-25       Impact factor: 2.777

5.  The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria.

Authors:  Stig Hill Christiansen; Ronan A Murphy; Kristian Juul-Madsen; Marlene Fredborg; Michael Lykke Hvam; Esben Axelgaard; Sandra M Skovdal; Rikke Louise Meyer; Uffe B Skov Sørensen; Arne Möller; Jens Randel Nyengaard; Niels Nørskov-Lauritsen; Mikala Wang; Mihaela Gadjeva; Kenneth A Howard; Jane C Davies; Eskild Petersen; Thomas Vorup-Jensen
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

Review 6.  Sub-inhibitory Effects of Antimicrobial Peptides.

Authors:  Alexey S Vasilchenko; Eugene A Rogozhin
Journal:  Front Microbiol       Date:  2019-05-24       Impact factor: 5.640

Review 7.  The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections.

Authors:  Patience Shumba; Srikanth Mairpady Shambat; Nikolai Siemens
Journal:  Toxins (Basel)       Date:  2019-06-11       Impact factor: 4.546

8.  A Paradox in Bacterial Pathogenesis: Activation of the Local Macrophage Inflammasome Is Required for Virulence of Streptococcus uberis.

Authors:  Nathan Archer; Sharon A Egan; Tracey J Coffey; Richard D Emes; M Filippa Addis; Philip N Ward; Adam M Blanchard; James A Leigh
Journal:  Pathogens       Date:  2020-11-28

Review 9.  The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent.

Authors:  Kylen E Ridyard; Joerg Overhage
Journal:  Antibiotics (Basel)       Date:  2021-05-29

10.  A point mutation in AgrC determines cytotoxic or colonizing properties associated with phenotypic variants of ST22 MRSA strains.

Authors:  Srikanth Mairpady Shambat; Nikolai Siemens; Ian R Monk; Disha B Mohan; Santhosh Mukundan; Karthickeyan Chella Krishnan; Sushma Prabhakara; Johanna Snäll; Angela Kearns; Francois Vandenesch; Mattias Svensson; Malak Kotb; Balasubramanian Gopal; Gayathri Arakere; Anna Norrby-Teglund
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.